Story · Medicine & Biotech · Nutrition
OW2026: Remarkable Clarity About Obesity at FDA
1 outlet · first reported by ConscienHealth on
One of the most encouraging moments at ObesityWeek 2026 came from an unlikely source: the FDA. Raymond Soccio , Division Director for Diabetes, Lipid Disorders, and Obesity at the agency, offered a remarkably candid and constructive update on the year in obesity medicine approvals and regulatory… (ConscienHealth)
Coverage, in order
-
OW2026: Remarkable Clarity About Obesity at FDA
One of the most encouraging moments at ObesityWeek 2026 came from an unlikely source: the FDA. Raymond Soccio , Division Director for Diabetes, Lipid Disorders, and Obesity at the agency, offered a remarkably candid and constructive update on the year in obesity medicine approvals and regulatory…
Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.